Seitaro Terakura

35PUBLICATIONS

75CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (35)

Sort by Publication Date:

|May 13, 2026

Impact of Glycine-Serine Linker on Target Antigen Binding and Subsequent CD37CAR-T Performance.

|Apr 13, 2026

BATF3 regulates differentiation of CD8<sup>+</sup> T lymphocytes and memory differentiation program.

Koji Umemura, Yasuhiro Kojima, Jakrawadee Julamanee

|Mar 11, 2026

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

Yuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa

|May 25, 2025

Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion.

Ryo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa

|May 09, 2025

Development and optimization of Eva1 (<i>MPZL2</i>) targeting chimeric antigen receptor T cells.

Masahide Osaki, Seitaro Terakura, Shiho Hirano

|Dec 10, 2024

Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Yoshitaka Adachi, Seitaro Terakura, Masahide Osaki

Pageof 6

Frequent Collaborators

Yoshiko Atsuta

Junya Kanda

Makoto Murata

Hitoshi Kiyoi

Tatsuo Ichinohe

Ryo Hanajiri

Naoyuki Uchida

Satoko Morishima

Yoshihiro Inamoto

Yoshitaka Adachi

Frequent Collaborators

Yoshiko Atsuta

Junya Kanda

Makoto Murata

Hitoshi Kiyoi